Ophthalmic epidemiology in Europe: the “European Eye Epidemiology” (E3) consortium

European Journal of Epidemiology

Volumn 31, Issue 2, 2016, Pages 197-210

  Delcourt, Cécile ^a,b   Korobelnik, Jean François ^a,b,c   Buitendijk, Gabriëlle H S ^d   Foster, Paul J ^e   Hammond, Christopher J ^f   Piermarocchi, Stefano ^g   Peto, Tunde ^e   Jansonius, Nomdo ^d,h   Mirshahi, Alireza ⁱ   Hogg, Ruth E ^j   Bretillon, Lionel ^k   Topouzis, Fotis ^l   Deak, Gabor ^m   Grauslund, Jakob ^n,o   Broe, Rebecca ^n,o   Souied, Eric H ^p   Creuzot Garcher, Catherine ^k,q   Sahel, José ^b,r,s,t,u,v   Daien, Vincent ^w,x,y   Lehtimäki, Terho ^z,aa   Hense, Hans Werner ^ab   Prokofyeva, Elena ^b,ac,ad   Oexle, Konrad ^ae   Rahi, Jugnoo S ^e,af   Cumberland, Phillippa M ^af   Schmitz Valckenberg, Steffen ^ag   Fauser, Sascha ^ah   Bertelsen, Geir ^ai,aj   Hoyng, Carel ^ak   Bergen, Arthur ^al   Silva, Rufino ^am,an,ao   Wolf, Sebastian ^ap   Lotery, Andrew ^aq   Chakravarthy, Usha ^j   Fletcher, Astrid ^ar   Klaver, Caroline C W ^d   more..

^a UNIVERSITÉ DE BORDEAUX   (France)

^b INSERM   (France)

^c BORDEAUX UNIVERSITY HOSPITAL   (France)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e MOORFIELDS EYE HOSPITAL   (United Kingdom)

^f ST THOMAS HOSPITAL   (United Kingdom)

^g UNIVERSITY OF PADOVA   (Italy)

^h UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

ⁱ UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^j QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^k CENTRE DES SCIENCES DU GOÛT ET DE L ALIMENTATION   (France)

^l ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^m MEDICAL UNIVERSITY OF VIENNA   (Austria)

ⁿ UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^o ODENSE UNIVERSITY HOSPITAL   (Denmark)

^p CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

^q DIJON UNIVERSITY HOSPITAL   (France)

^r INSTITUT DE LA VISION   (France)

^s CNRS   (France)

^t CENTRE HOSPITALIER NATIONAL D OPHTALMOLOGIE DES QUINZE VINGTS   (France)

^u FONDATION OPHTALMOLOGIQUE ADOLPHE DE ROTHSCHILD   (France)

^v UNIVERSITY COLLEGE LONDON   (United Kingdom)

^w INSERM U1061   (France)

^x UNIV MONTPELLIER   (France)

^y GUI DE CHAULIAC HOSPITAL   (France)

^z FIMLAB LABORATORIES   (Finland)

^aa TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^ab UNIVERSITY OF MÜNSTER   (Germany)

^ac LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^ad NORTHERN STATE MEDICAL UNIVERSITY   (Russian Federation)

^ae TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^af UNIVERSITY COLLEGE LONDON   (United Kingdom)

^ag UNIVERSITY OF BONN   (Germany)

^ah UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^ai UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^aj UNIVERSITY OF TROMSØ   (Norway)

^ak RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^al ACADEMIC MEDICAL CENTER   (Netherlands)

^am CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^an UNIVERSITY OF COIMBRA   (Portugal)

^ao ASSOCIATION FOR INNOVATION AND BIOMEDICAL RESEARCH ON LIGHT AND IMAGE AIBILI   (Portugal)

^ap UNIVERSITY OF BERN   (Switzerland)

^aq UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^ar LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

more..

Author keywords

Epidemiology; Europe; Eye diseases; Ophthalmology; Prevalence; Risk factors

Indexed keywords

BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; EPIDEMIOLOGICAL DATA; EPIGENETICS; EUROPE; EYE DISEASE; GEOGRAPHIC DISTRIBUTION; HUMAN; LIFESTYLE; METABOLISM; PREVALENCE; RISK FACTOR; VALIDATION STUDY; VASCULAR DISEASE; VISUAL IMPAIRMENT; CAUCASIAN; EPIDEMIOLOGY; EYE DISEASES; FEMALE; FORECASTING; OPHTHALMOLOGY;

EPIDEMIOLOGIC METHODS; EPIDEMIOLOGIC STUDIES; EUROPE; EUROPEAN CONTINENTAL ANCESTRY GROUP; EYE DISEASES; FEMALE; FORECASTING; HUMANS; OPHTHALMOLOGY; PREVALENCE; RISK FACTORS;

EID: 84950287668     PISSN: 03932990     EISSN: 15737284     Source Type: Journal    
DOI: 10.1007/s10654-015-0098-2     Document Type: Article

References (68)

1. McKean-Cowdin R, Varma R, Hays RD, et al. Longitudinal changes in visual acuity and health-related quality of life: the Los Angeles Latino Eye study. Ophthalmology. 2010;117:1900–7 (7 e1).
2. Seland JH, Vingerling JR, Augood CA, et al. Visual impairment and quality of life in the older European population, the EUREYE study. Acta Ophthalmol. 2011;89:608–13.
3. Lam BL, Christ SL, Zheng DD, et al. longitudinal relationships among visual acuity and tasks of everyday life: the Salisbury Eye Evaluation study. Invest Ophthalmol Vis Sci. 2013;54:193–200.
4. Daien V, Peres K, Villain M, et al. Visual acuity thresholds associated with activity limitations in the elderly. The Pathologies Oculaires Liees a l’Age study. Acta Ophthalmol. 2014;92:e500–6.
5. Carriere I, Delcourt C, Daien V, et al. A prospective study of the bi-directional association between vision loss and depression in the elderly. J Affect Disord. 2013;151:164–70.
6. Lamoureux EL, Fenwick E, Moore K, et al. Impact of the severity of distance and near-vision impairment on depression and vision-specific quality of life in older people living in residential care. Invest Ophthalmol Vis Sci. 2009;50:4103–9.
7. Patino CM, McKean-Cowdin R, Azen SP, et al. Central and peripheral visual impairment and the risk of falls and falls with injury. Ophthalmology. 2010;117(199–206):e1.
8. Yip JL, Khawaja AP, Broadway D, et al. Visual acuity, self-reported vision and falls in the EPIC-Norfolk Eye study. Br J Ophthalmol. 2014;98:377–82.
9. Gordois A, Cutler H, Pezzullo L, et al. An estimation of the worldwide economic and health burden of visual impairment. Glob Public Health. 2012;7:465–81.
10. Pascolini D, Mariotti SP. Global estimates of visual impairment: 2010. Br J Ophthalmol. 2012;96:614–8.
11. He M, Abdou A, Naidoo KS, et al. Prevalence and correction of near vision impairment at seven sites in China, India, Nepal, Niger, South Africa, and the United States. Am J Ophthalmol. 2012;154(107–16):e1.
12. World Health Organization. Action plan for the prevention of avoidable blindness and vision impairment, 2009–2013. 2010.
13. World Health Organization. Universal eye health: a global action plan 2014–2019. 2013.
14. Drexler W, Fujimoto JG. State-of-the-art retinal optical coherence tomography. Prog Retin Eye Res. 2008;27:45–88.
15. Asbell PA, Dualan I, Mindel J, et al. Age-related cataract. Lancet. 2005;365:599–609.
16. Leske MC, Chylack LT, He QM, et al. Risk factors for nuclear opalescence in a longitudinal study. Am J Epidemiol. 1998;147:36–41.
17. Delcourt C, Cristol JP, Tessier F, et al. Risk factors for cortical, nuclear, and posterior subcapsular cataracts: the POLA study. Pathologies Oculaires Liees a l’Age. Am J Epidemiol. 2000;151:497–504.
18. Christen WG, Glynn RJ, Ajani UA, et al. Smoking cessation and risk of age-related cataract in men. JAMA. 2000;284:713–6.
19. Prokofyeva E, Wegener A, Zrenner E. Cataract prevalence and prevention in Europe: a literature review. Acta Ophthalmol. 2013;91:395–405.
20. Vingerling JR, Hofman A, Grobbee DE, De Jong PT. Age-related macular degeneration and smoking. The Rotterdam Study. Arch Ophthalmol. 1996;114:1193–6.
21. Delcourt C, Diaz JL, Ponton-Sanchez A, Papoz L. Smoking and age-related macular degeneration. The POLA Study. Pathologies Oculaires Liees a l’Age. Arch Ophthalmol. 1998;116:1031–5.
22. Smith W, Assink J, Klein R, et al. Risk factors for age-related macular degeneration: pooled findings from three continents. Ophthalmology. 2001;108:697–704.
23. Chakravarthy U, Augood C, Bentham GC, et al. Cigarette smoking and age-related macular degeneration in the EUREYE Study. Ophthalmology. 2007;114:1157–63.
24. Lim LS, Mitchell P, Seddon JM, Holz FG, Wong TY. Age-related macular degeneration. Lancet. 2012;379:1728–38.
25. Erke MG, Bertelsen G, Peto T, et al. Cardiovascular risk factors associated with age-related macular degeneration: the Tromso Study. Acta Ophthalmol. 2014;92:662–9.
26. Klein R, Klein BE, Moss SE, Meuer SM. The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study. Trans Am Ophthalmol Soc. 2000;98:133–41 (discussion 41–3).
27. Cruickshanks KJ, Klein BE, Klein R. Ultraviolet light exposure and lens opacities: the Beaver Dam Eye Study. Am J Public Health. 1992;82:1658–62.
28. West SK, Duncan DD, Munoz B, et al. Sunlight exposure and risk of lens opacities in a population-based study: the Salisbury Eye Evaluation Project. JAMA. 1998;280:714–8.
29. Delcourt C, Carriere I, Ponton Sanchez A, et al. Light exposure and the risk of cortical, nuclear, and posterior subcapsular cataracts: the Pathologies Oculaires Liées à l’Age (POLA) Study. Arch Ophthalmol. 2000;118:385–92.
30. McCarty CA, Taylor HR. A review of the epidemiologic evidence linking ultraviolet radiation and cataracts. Dev Ophthalmol. 2002;35:21–31.
31. Delcourt C, Cougnard-Gregroire A, Boniol M, et al. Lifetime exposure to ambient ultraviolet radiation and the risk for cataract extraction and age-related macular degeneration: the Alienor Study. Invest Ophthalmol Vis Sci. 2014;55:7619–27.
32. Threlfall TJ, English DR. Sun exposure and pterygium of the eye: a dose-response curve. Am J Ophthalmol. 1999;128:280–7.
33. McCarty CA, Fu CL, Taylor HR. Epidemiology of pterygium in Victoria, Australia. Br J Ophthalmol. 2000;84:289–92.
34. Fletcher AE, Bentham GC, Agnew M, et al. Sunlight exposure, antioxidants, and age-related macular degeneration. Arch Ophthalmol. 2008;126:1396–403.
35. Seddon JM, Ajani UA, Sperduto RD, et al. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case–Control Study Group JAMA. 1994;272:1413–20.
36. Delcourt C, Cristol JP, Tessier F, et al. Age-related macular degeneration and antioxidant status in the POLA study. POLA Study Group. Pathologies Oculaires Liees a l’Age. Arch Ophthalmol. 1999;117:1384–90.
37. van Leeuwen R, Boekhoorn S, Vingerling JR, et al. Dietary intake of antioxidants and risk of age-related macular degeneration. JAMA. 2005;294:3101–7.
38. Tan JS, Wang JJ, Flood V, et al. Dietary antioxidants and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study. Ophthalmology. 2008;115:334–41.
39. Mares Perlman JA, Fisher AI, Klein R, et al. Lutein and zeaxanthin in the diet and serum and their relation to age-related maculopathy in the third national health and nutrition examination survey. Am J Epidemiol. 2001;153:424–32.
40. Delcourt C, Carriere I, Delage M, Barberger-Gateau P, Schalch W. Plasma lutein and zeaxanthin and other carotenoids as modifiable risk factors for age-related maculopathy and cataract: the POLA Study. Invest Ophthalmol Vis Sci. 2006;47:2329–35.
41. Ho L, van Leeuwen R, Witteman JC, et al. Reducing the genetic risk of age-related macular degeneration with dietary antioxidants, zinc, and ω-3 fatty acids: the Rotterdam study. Arch Ophthalmol. 2011;129:758–66.
42. Lyle BJ, Maresperlman JA, Klein BEK, Klein R, Greger JL. Antioxidant intake and risk of incident age-related nuclear cataracts in the Beaver Dam Eye Study. Am J Epidemiol. 1999;149:801–9.
43. Gale CR, Hall NF, Phillips DI, Martyn CN. Plasma antioxidant vitamins and carotenoids and age-related cataract. Ophthalmology. 2001;108:1992–8.
44. Christen WG, Liu S, Glynn RJ, Gaziano JM, Buring JE. Dietary carotenoids, vitamins C and E, and risk of cataract in women: a prospective study. Arch Ophthalmol. 2008;126:102–9.
45. Fletcher AE. Free radicals, antioxidants and eye diseases: evidence from epidemiological studies on cataract and age-related macular degeneration. Ophthalmic Res. 2010;44:191–8.
46. AREDS. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch. Arch Ophthalmol. 2001;119:1417–36.
47. Smith W, Mitchell P, Leeder SR. Dietary fat and fish intake and age-related maculopathy. Arch Ophthalmol. 2000;118:401–4.
48. Cho E, Hung S, Willett WC, et al. Prospective study of dietary fat and the risk of age-related macular degeneration. Am J Clin Nutr. 2001;73:209–18.
49. Seddon JM, Rosner B, Sperduto RD, et al. Dietary fat and risk for advanced age-related macular degeneration. Arch Ophthalmol. 2001;119:1191–9.
50. Delcourt C, Carriere I, Cristol JP, Lacroux A, Gerber M. Dietary fat and the risk of age-related maculopathy: the POLANUT study. Eur J Clin Nutr. 2007;61:1341–4.
51. SanGiovanni JP, Agron E, Clemons TE, Chew EY. Omega-3 long-chain polyunsaturated fatty acid intake inversely associated with 12-year progression to advanced age-related macular degeneration. Arch Ophthalmol. 2009;127:110–2.
52. Tan JS, Wang JJ, Flood V, Mitchell P. Dietary Fatty acids and the 10-year incidence of age-related macular degeneration: the blue mountains eye study. Arch Ophthalmol. 2009;127:656–65.
53. Merle B, Delyfer MN, Korobelnik JF, et al. Dietary omega-3 Fatty acids and the risk for age-related maculopathy: the alienor study. Invest Ophthalmol Vis Sci. 2011;52:6004–11.
54. Merle BM, Benlian P, Puche N, et al. Circulating omega-3 fatty acids and neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci. 2014;55:2010–9.
55. Augood C, Chakravarthy U, Young I, et al. Oily fish consumption, dietary docosahexaenoic acid and eicosapentaenoic acid intakes, and associations with neovascular age-related macular degeneration. Am J Clin Nutr. 2008;88:398–406.
56. Chiu CJ, Milton RC, Gensler G, Taylor A. Dietary carbohydrate intake and glycemic index in relation to cortical and nuclear lens opacities in the age-related Eye Disease study. Am J Clin Nutr. 2006;83:1177–84.
57. Chiu CJ, Robman L, McCarty CA, et al. Dietary carbohydrate in relation to cortical and nuclear lens opacities in the melbourne visual impairment project. Invest Ophthalmol Vis Sci. 2010;51:2897–905.
58. Mares JA, Voland R, Adler R, et al. Healthy diets and the subsequent prevalence of nuclear cataract in women. Arch Ophthalmol. 2010;128:738–49.
59. Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet. 2010;376:124–36.
60. Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2224–60.
61. Zins M, Bonenfant S, Carton M, et al. The CONSTANCES cohort: an open epidemiological laboratory. BMC Public Health. 2010;10:479.
62. Fritsche LG, Chen W, Schu M, et al. Seven new loci associated with age-related macular degeneration. Nat Genet. 2013;45:433–9 (9e1-2).
63. Verhoeven VJ, Hysi PG, Wojciechowski R, et al. Genome-wide meta-analyses of multiancestry cohorts identify multiple new susceptibility loci for refractive error and myopia. Nat Genet. 2013;45:314–8.
64. Hysi PG, Cheng CY, Springelkamp H, et al. Genome-wide analysis of multi-ancestry cohorts identifies new loci influencing intraocular pressure and susceptibility to glaucoma. Nat Genet. 2014;46:1126–30.
65. Buitendijk GH, Rochtchina E, Myers C, et al. Prediction of age-related macular degeneration in the general population: the Three Continent AMD Consortium. Ophthalmology. 2013;120:2644–55.
66. Bourne RR, Jonas JB, Flaxman SR, et al. Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe: 1990–2010. Br J Ophthalmol. 2014;98:629–38.
67. Williams KM, Verhoeven VJ, Cumberland P, et al. Prevalence of refractive error in Europe: the European Eye Epidemiology (E3) consortium. Eur J Epidemiol. 2015;30:305–15.
68. Williams KM, Bertelsen G, Cumberland P, et al. Increasing prevalence of Myopia in Europe and the impact of education. Ophthalmology. 2015;122:1489–97.